KITLG and breast carcinoma: Both preparations showed concentration-dependent cytotoxic activity on human breast carcinoma cells (MCF-7), with a half maximal inhibitory concentration (IC50) of 811 μg/mL and 437 μg/mL, respectively, with SCF being more cytotoxic.